| Literature DB >> 23302222 |
Anne Scherer1, Nicole Eberle, Maren Boecker, Claus Vögele, Siegfried Gauggel, Thomas Forkmann.
Abstract
BACKGROUND: Negative affect and difficulties in its regulation have been connected to several adverse psychological consequences. While several questionnaires exist, it would be important to have a theory-based measure that includes clinically relevant items and shows good psychometric properties in healthy and patient samples. This study aims at developing such a questionnaire, combining the two Gross [1] scales Reappraisal and Suppression with an additional response-focused scale called Externalizing Behavioral Strategies covering clinically relevant items.Entities:
Mesh:
Year: 2013 PMID: 23302222 PMCID: PMC3558324 DOI: 10.1186/1471-244X-13-16
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Demographic and clinical characteristics of the student and clinical groups and the total sample
| | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1053 | 27.7 | 11.0 | 15 - 81 | 59.8 | | |||
| 341 | 23.4 | 3.7 | 19 - 45 | 51.3 | | |||
| 343 | 23.0 | 3.4 | 18 - 50 | 55.8 | | |||
| 369 | 36.0 | 14.6 | 15 - 81 | 71.2 | 40.4% | 29.3% | 30.3% | |
Measures of global fit for all models estimated and Hierarchical model tests
| Thresholds for acceptable fit | | | > .05 | ≥ .90 | ≥ .90 | ≤ .08 |
| | | | | | | |
| Students I | 1697.0 | 99 | <.001 | .72 | .72 | .112 |
| | | | | | | |
| Students I | 1598.9 | 46 | <.001 | .96 | .96 | .064 |
| Students II | 1122.7 | 43 | <.001 | .93 | .94 | .067 |
| Clinical | 1915.2 | 38 | <.001 | .96 | .95 | .074 |
Figure 1Structure of the CFA model. Note: Bold numbers = First student sample, normal numbers = Second student sample, italic numbers = Clinical sample
Means and standard deviations of student sample and clinical subgroups
| | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 684 | 11.4 | 3.0 | 1 – 20 | 8.6 | 3.7 | 0 – 20 | 3.9 | 3.2 | 0 – 19 | |
| 147 | 9.1 | 3.5 | 0 – 17 | 10.7 | 4.0 | 1 – 20 | 4.6 | 3.7 | 0 – 14 | |
| 107 | 8.7 | 3.5 | 1 – 18 | 10.9 | 3.6 | 2 – 17 | 5.6 | 3.8 | 0 – 18 | |
| 115 | 10.0 | 3.0 | 3 – 20 | 10.8 | 3.6 | 1 – 18 | 4.8 | 4.1 | 0 – 18 | |
Note: Clinical sample sorted by first diagnosis. Further comorbid disorders may exist.
Means and standard deviations for the different subgroups
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 364 | 9.3 (3.4) | 0.68 (0.55- 0.81) | 364 | 10.7 (3.8) | −0.59 (−0.46 − -0.72) | 350 | 4.9 (3.9) | −0.29 (−0.16- −0.42) | |
| 670 | 11.4 (3.0) | 675 | 8.6 (3.6) | 673 | 3.9 (3.2) | ||||
| 314 | 11.0 (3.2) | 0.25 (0.09-0.40) | 312 | 10.0 (3.3) | −0.81 (−0.65 − -0.97) | 312 | 4.7 (3.5) | −0.44 (−0.29 − -0.60) | |
| 356 | 11.8 (2.8) | 363 | 7.3 (3.4) | 361 | 3.3 (2.8) | ||||
| 43 | 8.9 (3.4) | 0.13 (−0.19-0.45) | 43 | 11.8 (3.7) | −0.31 (0.01 − -0.63) | 44 | 9.0 (3.7) | −1.33 (−1.00 − -1.66) | |
| 318 | 9.3 (3.4) | 319 | 10.6 (3.8) | 304 | 4.3 (3.5) | ||||
Note: All comparisons except for Reappraisal and Suppression between BPD and other patients were significant (p < .001).